Literature DB >> 21467188

Multiple sclerosis in Hispanics: a study of clinical disease expression.

L Amezcua1, B T Lund, L P Weiner, T Islam.   

Abstract

BACKGROUND: Hispanics living with multiple sclerosis (MS) in the United States are not well defined.
OBJECTIVE: To describe the clinical characteristics of MS among Hispanic Whites (HW) in Southern California with those of non-Hispanic Whites (NHW).
METHODS: We performed a medical chart review to identify all cases of HW with MS (n = 125) who were treated at our institution during a 1-year period. We also identified cases of NHW with MS (100 NHW) treated at those clinics. All HW patients were interviewed to ascertain ancestry including detailed migration history. Disease progression was assessed by ambulatory disability and defined as Expanded Disability Status Scale (EDSS) score ≥6.
RESULTS: Compared with NHW, HW were more likely to have a relapsing-remitting form of MS and a younger age of onset (28.4 ± 0.97 years) with presenting symptoms of optic neuritis and transverse myelitis. However, overall ambulatory disability did not differ between HW and NHW. Migration to the US at age >15 years was associated with increased risk of disability in HW.
CONCLUSIONS: HW living in the USA may be at risk of developing MS at an earlier age compared with NHW. Migration history can play an important role in the management of HW with MS.

Entities:  

Mesh:

Year:  2011        PMID: 21467188     DOI: 10.1177/1352458511403025

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  15 in total

1.  Place of birth,age of immigration,and disability in Hispanics with multiple sclerosis.

Authors:  Lilyana Amezcua; David V Conti; Lihua Liu; Karina Ledezma; Annette M Langer-Goulda
Journal:  Mult Scler Relat Disord       Date:  2015-01       Impact factor: 4.339

2.  Multiple sclerosis in US minority populations: Clinical practice insights.

Authors:  Omar Khan; Mitzi J Williams; Lilyana Amezcua; Adil Javed; Kristin E Larsen; Jennifer M Smrtka
Journal:  Neurol Clin Pract       Date:  2015-04

3.  Perceptions of Multiple Sclerosis in Hispanic Americans: Need for Targeted Messaging.

Authors:  Ozioma Obiwuru; Sarah Joseph; Lihua Liu; Ana Palomeque; Leslie Tarlow; Annette M Langer-Gould; Lilyana Amezcua
Journal:  Int J MS Care       Date:  2017 May-Jun

4.  Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis.

Authors:  Lana Zhovtis Ryerson; Rivka Green; Gladyne Confident; Krupa Pandey; Benjamin Richter; Tamar Bacon; Carrie Sammarco; Lisa Laing; Jennifer Kalina; Ilya Kister
Journal:  Ther Adv Neurol Disord       Date:  2016-08-04       Impact factor: 6.570

Review 5.  Towards a global view of multiple sclerosis genetics.

Authors:  Huw R Morris; Ruth Dobson; Benjamin Meir Jacobs; Michelle Peter; Gavin Giovannoni; Alastair J Noyce
Journal:  Nat Rev Neurol       Date:  2022-09-08       Impact factor: 44.711

6.  Spinal cord lesions and disability in Hispanics with multiple sclerosis.

Authors:  L Amezcua; A Lerner; K Ledezma; D Conti; M Law; L Weiner; A Langer-Gould
Journal:  J Neurol       Date:  2013-08-03       Impact factor: 4.849

Review 7.  Race and ethnicity on MS presentation and disease course.

Authors:  Lilyana Amezcua; Jacob L McCauley
Journal:  Mult Scler       Date:  2020-01-22       Impact factor: 6.312

8.  Vitamin D levels in Hispanics with multiple sclerosis.

Authors:  Lilyana Amezcua; Rachel H Chung; David V Conti; Annette M Langer-Gould
Journal:  J Neurol       Date:  2012-05-16       Impact factor: 4.849

9.  Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.

Authors:  Owen Garrick; Ruben Mesa; Andrea Ferris; Edward S Kim; Edith Mitchell; Otis W Brawley; John Carpten; Keith D Carter; Joseph Coney; Robert Winn; Stephanie Monroe; Fabian Sandoval; Edith Perez; Mitzi Williams; Evan Grove; Quita Highsmith; Nicole Richie; Susan M Begelman; Asha S Collins; Jamie Freedman; Melissa S Gonzales; Gerren Wilson
Journal:  Ethn Dis       Date:  2022-01-20       Impact factor: 2.006

10.  Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.

Authors:  Laura Ordoñez-Boschetti; Roberto Rey; Ana Cruz; Arijit Sinha; Tracy Reynolds; Nadina Frider; Regina Alvarenga
Journal:  Adv Ther       Date:  2015-07-14       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.